Bacterial Conjunctivitis Drugs Market By Drug Class ( Fluoroquinolones, Aminoglycosides, Macrolides ), Industry Trends, Estimation & Forecast, 2017 - 2025

May 2018

 Pages: 184

 ERC 8485


Bacterial Conjunctivitis Drugs Market is expected to generate $435 million by the end of 2025.

The global bacterial conjunctivitis drugs market has experienced sluggish growth in past few years and it is expected that the growth would decline in years to come. Moreover, patents for key drugs such as Moxeza, Besivance, Vigamox, and Zymaxid are on the verge of expiring which may cause decline in the revenue generation in near future.

According to JAMA (Journal of the American Medical Association), half of the conjunctivitis patients in the U.S. are suffering from bacterial conjunctivitis, resulting in an increase in demand for effective drugs to treat the same. Patient assistance programs offered by drug suppliers and introduction of multi-drug resistant variants are also expected to spur the market growth. In addition to expiration of patents for drugs, tendency of self-medication among patients may also restrict the market growth. Asia-Pacific offers various opportunities for drug manufacturers due to increase in disposable income and support offered by governments for conjunctivitis drugs.

The report provides detailed qualitative and quantitative analysis of the global bacterial conjunctivitis drugs market. Market size and forecast in terms of value has been provided for the period - (2017 - 2025), for the segments namely drug class in each of the major regions of the world.

Global Bacterial Conjunctivitis Drugs Market Player Analysis -

The report presents detailed analysis of major players operating in global bacterial conjunctivitis drugs market. Some of the key players operating in the market are Actavis Plc., Bayer AG, Akorn, Inc., F.Hoffman La-Roche Ltd., Merck & Co., Inc., Novartis AG, InSite Vision Incorporated, Perrigo Company Plc., Santen Pharmaceutical Co., Ltd., and Pfizer, Inc.

Market Segmentation

Global bacterial conjunctivitis drugs market is segmented based on drug class and geography. Based on drug class, the market is classified into Fluoroquinolones, Aminoglycosides, Macrolides, and others. Geographical coverage has been provided for each of the major regions including North America, Europe, Asia-Pacific, South America and Rest of the World.

Bacterial Conjunctivitis Drugs Market Segmentation

By Drug Class
    • Fluoroquinolones
    • Aminoglycosides
    • Macrolides
    • Others

By Geography
    • North America
             o U.S.
             o Canada
             o Mexico
    • Europe
             o U.K
             o France
             o Germany
             o Italy
             o Spain
             o Rest of Europe
    • Asia-Pacific
             o Japan
             o China
             o India
             o Rest of Asia-Pacific
    • Rest of the World
             o Middle East
             o Latin America
             o Africa

Bacterial Conjunctivitis Drugs Market Key Players

• Actavis Plc.
• Bayer AG
• Akorn, Inc.
• F.Hoffman La-Roche Ltd.
• Merck & Co., Inc.
• Novartis AG
• InSite Vision Incorporated
• Perrigo Company Plc.
• Santen Pharmaceutical Co., Ltd.
• Pfizer, Inc.

Please fill in the form below to Request for Customized Report
Your personal details are safe and secured with us. Privacy Policy

To request sample copy of this report, please complete the form below verified and secure

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report. This also includes a 30 minute free analyst discussion post report purchase.

Your personal details are safe and secured with us. Privacy Policy

    What Information does this report contain?

    • What was the market size of the Bacterial Conjunctivitis Drugs Market in 2017 and the expected market size by 2025, along with the growth rate?
    • An in-depth analysis of the current impacting factors, opportunities and challenges/restraints in the market
    • Which are the largest revenue generating products, services or regions and their comparative growth rate?
    • Which technology is in trend and how would it evolve during the forecast period (2017 - 2025)?
    • Which are the leading companies in the Bacterial Conjunctivitis Drugs Market and their competitive positioning basis their market share, product portfolio, strategic attempts and business focus?

Purchase Options

Offers & Discounts

  • Chapter purchase
  • Historical market data
  • Country level data breakdown
  • Free customization*
  • Discounts for first time
  • Special pricing for
              non-business entities


  • We offer 20% free customization on every purchase.

Get in touch!